Stryker (SYK) and Wright Medical (WMGI) merger information including expected completion date and offer price are displayed in the deal information table below.
This deal was successfully consummated on November 10, 2020
| Merger Details | Value |
|---|---|
| Acquisition Target Stock Name | Wright Medical |
| Acquisition Target Stock Ticker | WMGI |
| Acquirer Stock Name | Stryker (SYK) |
| Announcement Date | November 4, 2019 |
| Expected Completion Date | November 10, 2020* |
| Offer Price | $30.75 |
| Payment Method | All Cash Deal, Tender Offer |
| Initial Announcement | SEC Filing |
| Investor Relations | julie.dewey@wright.com |
| Actual Completion Date | November 10, 2020 |
Wright Medical (NASDAQ: WMGI) Acquisition
The major Wright Medical (WMGI) merger news updates & events are listed below. An invaluable data source for traders & investors looking to familiarize themselves with the Stryker (SYK) takeover of Wright Medical (WMGI) and trade the merger arbitrage spread. Following the acquisition news and events section, there is in-depth company profile. For more proprietary Merger Arbitrage Limited content and analysis on the Wright Medical (WMGI) buyout, follow this link Wright Medical (WMGI). Change the ticker symbol as required to access news and acquisition details of additional merger stocks. The current merger arbitrage spread is available on our Spread Tracker page.
Receive instant FREE access to constantly updated WMGI news related to the current merger deal. Simply register by entering your email address to receive weekly publication updates.
Traders can also review similar deals by simply entering a ticker symbol into the search box in the menu bar above or click on an acquisition target stock ticker in the tag cloud at the foot of this article. For broader takeover news on other constituents of the T20 portfolio, please see our Spread Tracker News feed.
Wright Medical (NASDAQ: WMGI) Merger - Acquisition News and Events
Wright Medical Company Profile
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company primarily offers its products to orthopedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives, independent sales agencies, direct sales offices, and distributors. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.
